Liquidia Corp
For the period ended Jun 30, 2025. Filed Aug 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the three months ended June 30, 2025, the following Rule 10b5-1 trading arrangements (as defined in Item 408(a)(1)(i) of Regulation S-K) and non-Rule 10b5-1 trading arrangements (as defined in Item 408(c) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act were adopted, modified, or terminated by our directors and/or executive officers (as defined in Section 16 of the Exchange Act):
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| Name | | Title | | Date of Adoption or Modificationof Rule 10b5-1Trading Arrangement(1) | | Scheduled Expiration Date of Rule 10b5-1 Trading Arrangement | | Aggregate Number of Securitiesto Be Sold |
| Jason Adair | | Chief Business Officer | | 5/29/2025(2) | | 8/31/2026 | | 61,713 |
| Scott Moomaw | | Chief Commercial Officer | | 5/29/2025(2) | | 7/1/2026 | | 105,000 |
| Rajeev Saggar | | Chief Medical Officer | | 5/29/2025(2) | | 9/30/2026 | | 35,000 |
| (1) | Date of adoption of Rule 10b5-1 trading arrangements is in accordance with both the Company’s insider trading policy and applicable SEC rules and regulations. |
| (2) | The first trade pursuant to the Rule 10b5-1 trading arrangement will be, in accordance with both the Company’s insider trading policy and applicable SEC rules and regulations, on a date after the date of adoption of the Rule 10b5-1 trading arrangement. |
During the three months ended June 30, 2025, the Company did not adopt, modify, or terminate a Rule 10b5-1 trading arrangement (as defined in Item 408(a)(1)(i) of Regulation S-K) for the purchase or sale of securities of the Company,
whether or not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.